EAST BRUNSWICK, N.J. & BANGALORE, India--(BUSINESS WIRE)--Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading global information technology, consulting and business process services company, and Amrita Vishwa Vidyapeetham have jointly won the Aegis Graham Bell Award 2017 in the ‘Innovation in mHealth’ category. They were recognized for their joint initiative - ‘Redefining primary comfort using mHealth’ at the eighth edition of the Aegis Graham Bell Awards. The awards honor innovation in the ICT domain in India.
The Aegis Graham Bell Awards (AGBA) recognize organizations that have made a significant contribution to promoting innovation and entrepreneurship in the fields of telecom, social, mobility, analytics and cloud.
The Amrita School of Biotechnology, Amrita Vishwa Vidyapeetham, in collaboration with Wipro has developed a mobile health solution using a novel glucose monitoring system integrated with a cloud-based monitoring application for providing more efficient and effective diabetes care. The initiative was supported by Biotechnology Industry Research Assistance Council (BIRAC), Government of India.
The jointly-developed Wipro-Amrita Diabetes Management Solution will provide a cost-effective, non-enzymatic glucose sensing solution for diabetes care, while promoting a healthy diet and active lifestyle, which are vital to manage diabetes. The solution will also enhance health screening and early diagnosis, contribute towards better adherence to drug and dietary regimen, encourage diabetes self-care activities and help prevent complications in patients with diabetes.
This end-to-end diabetes management solution requires a robust digital backbone and is based on proven algorithms that leverage the expertise of Wipro Digital.
Jeffrey Heenan Jalil, Senior Vice-President and Global Head, Healthcare, Life Sciences & Services, Wipro Limited said, “We are delighted and honored to receive this award as it reinforces our commitment to helping organizations improve peoples’ lives. At Wipro, we are focusing time and research on technological innovations that will help health systems in treating the most prevalent disease states. By offering the ‘mHealth’ solution in collaboration with Amrita, we are helping accelerate and optimize diabetes prevention and care to all people, including those who live in the most remote areas.”
“We congratulate Wipro and Amrita Vishwa Vidyapeetham for this breakthrough innovation in diabetic health care which will offer millions of diabetic patients an easy to use mobile app. This initiative also exemplifies industry-academia collaboration for research and innovation in healthcare,” said Bhupesh Daheria, Trustee, Aegis Knowledge Trust and Founder and CEO, Aegis School of Business, Data Science & Telecom, mUniversity, Aegis Graham Bell Awards & Data Science Congress.
Dr. Bipin Nair, Professor and Dean, Amrita Vishwa Vidyapeetham said, “We are honored to receive this award. It is a testimony to not just the novel, first-of-its kind diabetes management solution that has been developed, but also underscores the potential of what can be achieved in the healthcare sector through unique partnerships such as the one we have with Wipro. We are grateful for the support provided by BIRAC and happy to be recognized for our efforts to address the growing issue of diabetes in India, and help patients avail treatment at an affordable cost.”
About Wipro Limited
Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO) is a leading global information technology, consulting and business process services company. We harness the power of cognitive computing, hyper-automation, robotics, cloud, analytics and emerging technologies to help our clients adapt to the digital world and make them successful. A company recognized globally for its comprehensive portfolio of services, strong commitment to sustainability and good corporate citizenship, we have over 160,000 dedicated employees serving clients across six continents. Together, we discover ideas and connect the dots to build a better and a bold new future.
About the Aegis Graham Bell Awards
The Aegis Graham Bell Award is the largest innovation award for the ICT domain in India. The Aegis School of Business, Data Science, Cyber Security and Telecommunication has established the Aegis Graham Bell Award as a tribute to the father of the telephony, Alexander Graham Bell. This Award is intended to promote innovation, entrepreneurship in the field of Telecom, Social, Mobility, Analytics, Cloud, and Security to provide recognition for outstanding contributions by the innovators. The Award is organized with support of the Cellular Operators Association of India (COAI), and Telecom Centres of Excellence (TCOE), Convergence India and Deloitte as a knowledge partner.
Forward-looking and Cautionary Statements
Certain statements in this release concerning our future growth prospects are forward-looking statements, which involve a number of risks, and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding fluctuations in our earnings, revenue and profits, our ability to generate and manage growth, intense competition in IT services, our ability to maintain our cost advantage, wage increases in India, our ability to attract and retain highly skilled professionals, time and cost overruns on fixed-price, fixed-time frame contracts, client concentration, restrictions on immigration, our ability to manage our international operations, reduced demand for technology in our key focus areas, disruptions in telecommunication networks, our ability to successfully complete and integrate potential acquisitions, liability for damages on our service contracts, the success of the companies in which we make strategic investments, withdrawal of fiscal governmental incentives, political instability, war, legal restrictions on raising capital or acquiring companies outside India, unauthorized use of our intellectual property, and general economic conditions affecting our business and industry. Additional risks that could affect our future operating results are more fully described in our filings with the United States Securities and Exchange Commission. These filings are available at www.sec.gov. We may, from time to time, make additional written and oral forward-looking statements, including statements contained in the company’s filings with the Securities and Exchange Commission and our reports to shareholders. We do not undertake to update any forward-looking statement that may be made from time to time by us or on our behalf.